TrialAmerican journal of hematology2015

Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.

Deepa Manwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.